Related Experiment Videos
Continuous peritoneal dialysis-associated peritonitis: a review and current concepts
Laura Troidle1, Nancy Gorban-Brennan, Alan Kliger
1New Haven CAPD, Renal Research Institute, New Haven, Connecticut, USA.
Seminars in Dialysis
|November 25, 2003
Summary
Continuous peritoneal dialysis (CPD) use is declining due to peritonitis complications. While peritonitis rates have decreased, outcomes remain poor, necessitating further research into antibiotic dosing and biofilm management.
Area of Science:
- Nephrology
- Infectious Diseases
Background:
- Continuous peritoneal dialysis (CPD) use is decreasing in the US.
- Peritonitis is a major complication of CPD, impacting patient morbidity and mortality.
- Despite improvements, peritonitis outcomes remain unacceptable.
Purpose of the Study:
- To review the challenges and limitations in managing peritonitis in CPD patients.
- To identify areas for future research to improve peritonitis outcomes.
- To explore optimal management strategies for CPD-related peritonitis.
Main Methods:
- Literature review focusing on peritonitis in CPD patients.
- Analysis of factors contributing to peritonitis incidence and severity.
- Identification of knowledge gaps in antibiotic therapy and biofilm biology.
Main Results:
- Peritonitis remains a significant cause of morbidity and mortality in CPD patients.
- Lack of data on antibiotic dosing for continuous cycling peritoneal dialysis (CCPD) is a key issue.
- Bacterial biofilm biology and antibiotic resistance complicate peritonitis management.
Conclusions:
- Further research is needed on antibiotic dosing and biofilm management in CPD.
- Optimal peritoneal catheter management and the feasibility of resuming CPD after catheter removal require investigation.
- Improving peritonitis outcomes is crucial for the future of CPD therapy.